sotalol mylan 80 mg tabletti
mylan ab - sotalol hydrochloride - tabletti - 80 mg - sotaloli
sotalol mylan 160 mg tabletti
mylan ab - sotaloli hydrochloridum - tabletti - 160 mg - sotaloli
bisoprolol ratiopharm 2.5 mg tabletti
ratiopharm gmbh - bisoprolol fumarate - tabletti - 2.5 mg - bisoprololi
zeposia
bristol-myers squibb pharma eeig - ozanimod hydrochloride - multiple sclerosis, relapsing-remitting; colitis, ulcerative - immunosuppressantit - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.
victrelis
merck sharp dohme ltd - bosepreviirin - hepatiitti c, krooninen - antiviraalit systeemiseen käyttöön - victrelis on indisoitu kroonisen hepatiitti (chc) genotyyppi-1 infektio yhdessä peginterferoni alfa ja ribaviriini potilailla palkalliset maksasairaus aikuisten jotka ovat aiemmin tai jotka eivät ole aiemmin hoitoa.
bisoprolol ratiopharm 5 mg tabletti
ratiopharm gmbh - bisoprolol fumarate - tabletti - 5 mg - bisoprololi
bisoprolol ratiopharm 10 mg tabletti
ratiopharm gmbh - bisoprolol fumarate - tabletti - 10 mg - bisoprololi
verpamil 2.5 mg/ml injektioneste, liuos
orion corporation - verapamili hydrochloridum - injektioneste, liuos - 2.5 mg/ml - verapamiili
verpamil 40 mg tabletti, kalvopäällysteinen
orion corporation - verapamili hydrochloridum - tabletti, kalvopäällysteinen - 40 mg - verapamiili
verpamil 80 mg tabletti, kalvopäällysteinen
orion corporation - verapamil hydrochloride - tabletti, kalvopäällysteinen - 80 mg - verapamiili